(20:21): And we now have a really large phase three study ongoing, but of course, it's a hypothesis, right
With the caveat that this case series includes only four cases, it appears that narrower optic nerve heads may pose a greater risk for semaglutide-associated NAION, potentially independent of systemic risk factors
These programs may provide: Copay cards Reduce out-of-pocket costs for insured patients Free medication programs For patients meeting income requirements Sliding scale pricing Adjusted costs based on financial need Compounding Pharmacies Some compounding pharmacies create customized versions of GLP-1 medications that may cost less than brand-name options
Compounded tirzepatide formulations vary too much between pharmacies to support standardized studies, making it impossible to assume they'll produce the same outcomes documented in Zepbound's trials
You cannot simply swap the pens
Ive tried other options before, including semaglutide,but this has given me the best results so far